Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine for late-life treatment-resistant depression
NCT01071538Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- May 2010
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in major depressive disorder (MDD), sponsored by University of Pittsburgh. Started May 2010; status: completed.
02
Drugs
buprenorphine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01071538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071538.